Found: 47
Select item for more details and to access through your institution.
Outcomes of Percutaneous Endoscopic Gastrostomy in Huntington's Disease at a Tertiary Center.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 8, p. 998, doi. 10.1002/mdc3.14130
- By:
- Publication type:
- Article
Characterizing White Matter in Huntington's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2020, v. 7, n. 1, p. 52, doi. 10.1002/mdc3.12866
- By:
- Publication type:
- Article
Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 4, p. 302, doi. 10.1002/mdc3.12742
- By:
- Publication type:
- Article
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 4, p. 582, doi. 10.1002/mdc3.12483
- By:
- Publication type:
- Article
George Huntington: a legacy of inquiry, empathy and hope.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of a targeted proteomic assay for the quantitation of neurofilament light in cerebrospinal fluid: Correlation with Simoa‐based quantitation across neurodegenerative diseases and centres.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079668
- By:
- Publication type:
- Article
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 10, p. 1, doi. 10.1172/JCI64565
- By:
- Publication type:
- Article
Lumbar puncture safety and tolerability in premanifest and manifest Huntington's disease: a multi-analysis cross-sectional study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21934-6
- By:
- Publication type:
- Article
P3-377: A novel pathogenic pathway of immune activation detectable before cinical onset in Huntington's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00443-8
- By:
- Publication type:
- Article
A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01206-2
- By:
- Publication type:
- Article
Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0022966
- By:
- Publication type:
- Article
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 2, p. 539, doi. 10.1111/jnc.15360
- By:
- Publication type:
- Article
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2021, v. 158, n. 1, p. 539, doi. 10.1111/jnc.15360
- By:
- Publication type:
- Article
Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease.
- Published in:
- Journal of Neurology, 2009, v. 256, n. 2, p. 203, doi. 10.1007/s00415-009-0052-x
- By:
- Publication type:
- Article
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0233820
- By:
- Publication type:
- Article
Huntington's disease: fighting on many fronts.
- Published in:
- Brain: A Journal of Neurology, 2012, v. 135, n. 4, p. 998, doi. 10.1093/brain/aws060
- By:
- Publication type:
- Article
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntingtons disease.
- Published in:
- Brain: A Journal of Neurology, 2008, v. 131, n. 11, p. 2851, doi. 10.1093/brain/awn212
- By:
- Publication type:
- Article
Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 1979, doi. 10.1172/JCI80743
- By:
- Publication type:
- Article
Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 1, p. 126, doi. 10.1002/acn3.51252
- By:
- Publication type:
- Article
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 458, p. 1, doi. 10.1126/scitranslmed.aat7108
- By:
- Publication type:
- Article
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
- Published in:
- European Journal of Neuroscience, 2019, v. 49, n. 12, p. 1632, doi. 10.1111/ejn.14356
- By:
- Publication type:
- Article
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2016, v. 139, n. 1, p. 22, doi. 10.1111/jnc.13719
- By:
- Publication type:
- Article
CSF neurofilament light chain profiling and quantitation in neurological diseases.
- Published in:
- Brain Communications, 2024, v. 6, n. 3, p. 1, doi. 10.1093/braincomms/fcae132
- By:
- Publication type:
- Article
Translatable plasma and CSF biomarkers for use in mouse models of Huntington's disease.
- Published in:
- Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcae030
- By:
- Publication type:
- Article
Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
- Published in:
- Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac258
- By:
- Publication type:
- Article
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83000-x
- By:
- Publication type:
- Article
Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 10, p. 1937, doi. 10.1093/hmg/ddr075
- By:
- Publication type:
- Article
Natural history and burden of Huntington's disease in the UK: A population‐based cohort study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2249, doi. 10.1111/ene.15385
- By:
- Publication type:
- Article
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163479
- By:
- Publication type:
- Article
Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children.
- Published in:
- Movement Disorders, 2022, v. 37, n. 7, p. 1526, doi. 10.1002/mds.29027
- By:
- Publication type:
- Article
One decade ago, one decade ahead in huntington's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
- Published in:
- Journal of Neuroscience, 2021, v. 41, n. 4, p. 780, doi. 10.1523/JNEUROSCI.1865-20.2020
- By:
- Publication type:
- Article
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 574, p. 1, doi. 10.1126/scitranslmed.abc2888
- By:
- Publication type:
- Article
Ghost Pills: A Case Report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Ghost Pills: A Case Report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targets for future clinical trials in Huntington's disease: What's in the pipeline?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1434, doi. 10.1002/mds.26007
- By:
- Publication type:
- Article
Targets for future clinical trials in Huntington's disease: what's in the pipeline?
- Published in:
- 2014
- By:
- Publication type:
- journal article
Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 7, p. 888, doi. 10.1002/mds.22969
- By:
- Publication type:
- Article
Serial volumetric MRI in Parkinsonian disorders.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 6, p. 932, doi. 10.1002/mds.22485
- By:
- Publication type:
- Article
Serial volumetric MRI in Parkinsonian disorders.
- Published in:
- Movement Disorders, 2009, v. 24, n. S2, p. S691, doi. 10.1002/mds.22500
- By:
- Publication type:
- Article
Huntington's disease phenocopies are clinically and genetically heterogeneous.
- Published in:
- Movement Disorders, 2008, v. 23, n. 5, p. 716, doi. 10.1002/mds.21915
- By:
- Publication type:
- Article
Quantification of huntingtin protein species in Huntington’s disease patient leukocytes using optimised electrochemiluminescence immunoassays.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189891
- By:
- Publication type:
- Article